221 related articles for article (PubMed ID: 32511403)
1. Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids.
Han Y; Yang L; Duan X; Duan F; Nilsson-Payant BE; Yaron TM; Wang P; Tang X; Zhang T; Zhao Z; Bram Y; Redmond D; Houghton S; Nguyen D; Xu D; Wang X; Uhl S; Huang Y; Johnson JL; Xiang J; Wang H; Pan FC; Cantley LC; tenOever BR; Ho DD; Evans T; Schwartz RE; Chen HJ; Chen S
bioRxiv; 2020 May; ():. PubMed ID: 32511403
[TBL] [Abstract][Full Text] [Related]
2. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
Han Y; Duan X; Yang L; Nilsson-Payant BE; Wang P; Duan F; Tang X; Yaron TM; Zhang T; Uhl S; Bram Y; Richardson C; Zhu J; Zhao Z; Redmond D; Houghton S; Nguyen DT; Xu D; Wang X; Jessurun J; Borczuk A; Huang Y; Johnson JL; Liu Y; Xiang J; Wang H; Cantley LC; tenOever BR; Ho DD; Pan FC; Evans T; Chen HJ; Schwartz RE; Chen S
Nature; 2021 Jan; 589(7841):270-275. PubMed ID: 33116299
[TBL] [Abstract][Full Text] [Related]
3. The Human Nose Organoid Respiratory Virus Model: an
Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
[TBL] [Abstract][Full Text] [Related]
4. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence.
Han Y; Yang L; Kim TW; Nair MS; Harschnitz O; Wang P; Zhu J; Koo SY; Tang X; Lacko LA; Chandar V; Bram Y; Zhang T; Zhang W; He F; Caicedo J; Huang Y; Evans T; van der Valk P; Titulaer MJ; Spoor JKH; Furler RL; Canoll P; Goldman JE; Przedborski S; Schwartz RE; Ho DD; Studer L; Chen S
Res Sq; 2021 May; ():. PubMed ID: 34031650
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids
Kim MJ; Kim S; Kim H; Gil D; Han HJ; Thimmulappa RK; Choi JH; Kim JH
Emerg Microbes Infect; 2023 Dec; 12(1):2211685. PubMed ID: 37161660
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
9. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection.
Duan X; Tang X; Nair MS; Zhang T; Qiu Y; Zhang W; Wang P; Huang Y; Xiang J; Wang H; Schwartz RE; Ho DD; Evans T; Chen S
Cell Rep; 2021 Nov; 37(6):109920. PubMed ID: 34731648
[TBL] [Abstract][Full Text] [Related]
10. Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids.
Krüger J; Groß R; Conzelmann C; Müller JA; Koepke L; Sparrer KMJ; Weil T; Schütz D; Seufferlein T; Barth TFE; Stenger S; Heller S; Münch J; Kleger A
Cell Mol Gastroenterol Hepatol; 2021; 11(4):935-948. PubMed ID: 33186749
[TBL] [Abstract][Full Text] [Related]
11. A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection.
Tang X; Xue D; Zhang T; Nilsson-Payant BE; Carrau L; Duan X; Gordillo M; Tan AY; Qiu Y; Xiang J; Schwartz RE; tenOever BR; Evans T; Chen S
Nat Cell Biol; 2023 Mar; 25(3):381-389. PubMed ID: 36918693
[TBL] [Abstract][Full Text] [Related]
12. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.
Samuel RM; Majd H; Richter MN; Ghazizadeh Z; Zekavat SM; Navickas A; Ramirez JT; Asgharian H; Simoneau CR; Bonser LR; Koh KD; Garcia-Knight M; Tassetto M; Sunshine S; Farahvashi S; Kalantari A; Liu W; Andino R; Zhao H; Natarajan P; Erle DJ; Ott M; Goodarzi H; Fattahi F
Cell Stem Cell; 2020 Dec; 27(6):876-889.e12. PubMed ID: 33232663
[TBL] [Abstract][Full Text] [Related]
13. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
mBio; 2020 May; 11(3):. PubMed ID: 32444382
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
[TBL] [Abstract][Full Text] [Related]
15. Diesel Particulate Matter 2.5 Induces Epithelial-to-Mesenchymal Transition and Upregulation of SARS-CoV-2 Receptor during Human Pluripotent Stem Cell-Derived Alveolar Organoid Development.
Kim JH; Kim J; Kim WJ; Choi YH; Yang SR; Hong SH
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33202948
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection causes dopaminergic neuron senescence.
Yang L; Kim TW; Han Y; Nair MS; Harschnitz O; Zhu J; Wang P; Koo SY; Lacko LA; Chandar V; Bram Y; Zhang T; Zhang W; He F; Pan C; Wu J; Huang Y; Evans T; van der Valk P; Titulaer MJ; Spoor JKH; Furler O'Brien RL; Bugiani M; D J Van de Berg W; Schwartz RE; Ho DD; Studer L; Chen S
Cell Stem Cell; 2024 Feb; 31(2):196-211.e6. PubMed ID: 38237586
[TBL] [Abstract][Full Text] [Related]
17. Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2.
Duan F; Guo L; Yang L; Han Y; Thakur A; Nilsson-Payant BE; Wang P; Zhang Z; Yan Ma C; Zhou X; Han T; Zhang T; Wang X; Xu D; Duan X; Xiang J; Tse HF; Liao C; Luo W; Huang FP; Chen YW; Evans T; Schwartz RE; tenOever B; Ho DD; Chen S; Na J; Lian Q; Chen HJ
Res Sq; 2020 Sep; ():. PubMed ID: 32839764
[TBL] [Abstract][Full Text] [Related]
18. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
[TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infections In Vitro.
Bose B; Kapoor S; Nihad M
Adv Exp Med Biol; 2021; 1312():1-17. PubMed ID: 33385178
[TBL] [Abstract][Full Text] [Related]
20. Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models.
Lee JE; Jeong SY; Li Z; Kim HY; Kim HW; Yoo MJ; Jang HJ; Kim DK; Cho N; Yoo HM; Kim KH
Biomater Res; 2023 Mar; 27(1):18. PubMed ID: 36855173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
